Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) - Azide and BSA Free | Novus Biologicals NBP2-52709-0.2mg product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) - Azide and BSA Free

catalog :

NBP2-52709-0.2mg

quantity :

0.2 mg (also 0.025 mg)

price :

489 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

D1-4G2-4-15 (4G2)

application :

western blot, ELISA, immunohistochemistry, immunocytochemistry, neutralization, flow cytometry, immunohistochemistry - paraffin section

more info or order :

Novus Biologicals product webpage

citations: 22

Reference
Victorio C, Ganasarajah A, Novera W, Ong J, Msallam R, Chacko A. Translocator protein (TSPO) is a biomarker of Zika virus (ZIKV) infection-associated neuroinflammation. Emerg Microbes Infect. 2024;13:2348528 pubmed publisher
Victorio C, Novera W, Ganasarajah A, Ong J, Thomas M, Wu J, et al. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells. J Transl Med. 2024;22:126 pubmed publisher
Liu M, Chen Y, Twu N, Wu M, Fang Z, Dubruel A, et al. A novel goose-origin Tembusu virus exhibits pathogenicity in day-old chicks with evidence of direct contact transmission. Poult Sci. 2024;103:103332 pubmed publisher
Grunwald V, Ngo H, Formanski J, Jonas J, P xf6 hlking C, Schwalbe B, et al. Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells. Int J Mol Sci. 2023;24: pubmed publisher
Johnson R, Stopard I, Byrne H, Armstrong P, Brackney D, Lambert B. Investigating the dose-dependency of the midgut escape barrier using a mechanistic model of within-mosquito dengue virus population dynamics. bioRxiv. 2023;: pubmed publisher
Fang E, Li M, Liu X, Hu K, Liu L, Zhang Z, et al. NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus. Vaccines (Basel). 2023;11: pubmed publisher
Jeong G, Lee S, Kim D, Lyu J, Yoon G, Kim K, et al. Zika Virus Infection Induces Interleukin-1β-Mediated Inflammatory Responses by Macrophages in the Brain of an Adult Mouse Model. J Virol. 2023;97:e0055623 pubmed publisher
Kedarinath K, Fox C, Crowgey E, Mazar J, Phelan P, Westmoreland T, et al. CD24 Expression Dampens the Basal Antiviral State in Human Neuroblastoma Cells and Enhances Permissivity to Zika Virus Infection. Viruses. 2022;14: pubmed publisher
Martinez Liu C, Machain Williams C, Martinez Acu xf1 a N, Lozano Sepulveda S, Galan Huerta K, Arellanos Soto D, et al. Development of a Rapid Gold Nanoparticle-Based Lateral Flow Immunoassay for the Detection of Dengue Virus. Biosensors (Basel). 2022;12: pubmed publisher
Fonseka C, Hardman C, Woo J, Singh R, Nahler J, Yang J, et al. Dengue virus co-opts innate type 2 pathways to escape early control of viral replication. Commun Biol. 2022;5:735 pubmed publisher
Gallichotte E, Henein S, Nivarthi U, Delacruz M, Scobey T, Bonaparte M, et al. Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity. Cell Rep. 2022;39:110930 pubmed publisher
Lim Z, Ng Q, Oo Y, Chu J, Ng S, Sze S, et al. Enterovirus-A71 exploits peripherin and Rac1 to invade the central nervous system. EMBO Rep. 2021;22:e51777 pubmed publisher
Wollner C, Richner M, Hassert M, Pinto A, Brien J, Richner J. A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses. J Virol. 2021;95: pubmed publisher
Francese R, Civra A, Donalisio M, Volpi N, Capitani F, Sottemano S, et al. Anti-Zika virus and anti-Usutu virus activity of human milk and its components. PLoS Negl Trop Dis. 2020;14:e0008713 pubmed publisher
Riva V, Garbelli A, Brai A, Casiraghi F, Fazi R, Trivisani C, et al. Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses. J Med Chem. 2020;63:9876-9887 pubmed publisher
Leier H, Weinstein J, Kyle J, Lee J, Bramer L, Stratton K, et al. A global lipid map defines a network essential for Zika virus replication. Nat Commun. 2020;11:3652 pubmed publisher
Vicenti I, Dragoni F, Giannini A, Giammarino F, Spinicci M, Saladini F, et al. Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. SLAS Discov. 2020;25:506-514 pubmed publisher
Wang S, Zhang Q, Tiwari S, Lichinchi G, Yau E, Hui H, et al. Integrin αvβ5 Internalizes Zika Virus during Neural Stem Cells Infection and Provides a Promising Target for Antiviral Therapy. Cell Rep. 2020;30:969-983.e4 pubmed publisher
Dragoni F, Boccuto A, Picarazzi F, Giannini A, Giammarino F, Saladini F, et al. Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro. Antiviral Res. 2020;175:104708 pubmed publisher
Durham N, Agrawal A, Waltari E, Croote D, Zanini F, Fouch M, et al. Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics. elife. 2019;8: pubmed publisher
Vogt M, Lahon A, Arya R, Spencer Clinton J, Rico Hesse R. Dengue viruses infect human megakaryocytes, with probable clinical consequences. PLoS Negl Trop Dis. 2019;13:e0007837 pubmed publisher
O Donnell K, Meberg B, Schiltz J, Nilles M, Bradley D. Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement. Viruses. 2019;11: pubmed publisher

product information

master code :

NBP2-52709

SKU :

NBP2-52709-0.2mg

product name :

Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) - Azide and BSA Free

unit size :

0.2 mg (also 0.025 mg)

description :

The Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) - Azide and BSA Free from Novus is a mouse monoclonal antibody to Flavivirus group antigen. This antibody reacts with human,primate - macaca mulatta (rhesus macaque),virus,virus - hpv. The Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) - Azide and BSA Free has been validated for the following applications: Immunohistochemistry,ELISA,Flow Cytometry,Western Blot,Immunocytochemistry,Block/Neutralize,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry-Paraffin,Neutralization,Immunofluorescence,CyTOF-ready.

target :

Flavivirus group antigen

category :

Primary Antibodies

buffer :

PBS

clonality :

Monoclonal

clone :

D1-4G2-4-15 (4G2)

concentration :

1 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

This recombinant Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) was prepared from Dengue Virus type 2 antigens.

isotype :

IgG2a Kappa

purity :

Protein A purified

species :

Human,Primate - Macaca mulatta (Rhesus Macaque),Virus,Virus - HPV

specificity :

This Flavivirus group antigen Antibody (D1-4G2-4-15 (4G2)) recognises flavivirus group specific antigens (Dengue virus, West Nile Virus, Japanese Encephalitis, Yellow Fever Virus, Zika virus etc)

applications :

Immunohistochemistry,ELISA,Flow Cytometry,Western Blot,Immunocytochemistry,Block/Neutralize,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry-Paraffin,Neutralization,Immunofluorescence,CyTOF-ready

extended description :

Recombinant Monoclonal Antibody

USD :

489 USD

product details :

Recombinant Monoclonal Antibody

alt names :

Envelope Protein, Protein E

storage :

Store at 4C for up to 3 months. For longer storage, aliquot and store at -20C.

more info or order :

Novus Biologicals product webpage